Hemostemix Inc. The Canadian Biotech company listed on TSX-V
Hemostemix is a public biotechnology-based company listed on TSX-V, with $HEM as the ticker symbol. Hemostemix is right now zeroing in on propelling its leading candidate, ACP-01, an autologous cell treatment, which as of its 2nd phase clinical trial in the United States and Canada.